Subscribe to RSS
DOI: 10.1055/s-0032-1333481
Endometriosis and Assisted Reproductive Technologies: Maximizing Outcomes
Publication History
Publication Date:
27 February 2013 (online)
Abstract
In vitro fertilization (IVF) represents the most efficient means of overcoming endometriosis-related infertility. Compromised pelvic anatomy and a hostile peritoneal environment are bypassed. Despite the results of early trials, more contemporary outcomes data would suggest that when controlled for age, IVF cycle outcome is not compromised by the presence of endometriosis. One exception to this concept is the finding that patients with ovarian endometriomas demonstrate poorer response to gonadotropin therapy, although it is not clear that this affects the likelihood of implantation. Surgical ablation of superficial endometriosis has no clear impact on IVF pregnancy rates, although a small number of recent trials suggest that pre-cycle resection of deeply infiltrative disease may be beneficial. With the exception of traditional gynecologic indications, there is no evidence to suggest that resection of ovarian endometriomas has any positive impact on cycle outcome. There are, in fact, data demonstrating that resection may exert a deleterious effect on ovarian reserve. A subset of patients will benefit from administration of a prolonged course of a gonadotropin-releasing hormone agonist prior to an IVF cycle. However, the characteristics of that subset have not been identified. It would be logical to consider this approach in women with more advanced disease, severe symptoms, and a history of implantation failure. Data on the impact of other pre-cycle medical interventions such as aromatase inhibitors, danazol, or oral contraceptives are more limited. There is also no evidence to suggest that the ovarian stimulation associated with IVF induces progression of endometriosis.
-
References
- 1 Society for Assisted Reproductive Technology. 2010 Clinic summary report. Available at: www.sartcorsonline.com
- 2 Bergendal A, Naffah S, Nagy C, Bergqvist A, Sjöblom P, Hillensjö T. Outcome of IVF in patients with endometriosis in comparison with tubal-factor infertility. J Assist Reprod Genet 1998; 15 (9) 530-534
- 3 Arici A, Oral E, Bukulmez O, Duleba A, Olive DL, Jones EE. The effect of endometriosis on implantation: results from the Yale University in vitro fertilization and embryo transfer program. Fertil Steril 1996; 65 (3) 603-607
- 4 Wardle PG, Mitchell JD, McLaughlin EA, Ray BD, McDermott A, Hull MG. Endometriosis and ovulatory disorder: reduced fertilisation in vitro compared with tubal and unexplained infertility. Lancet 1985; 2 (8449) 236-239
- 5 Simón C, Gutiérrez A, Vidal A , et al. Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation. Hum Reprod 1994; 9 (4) 725-729
- 6 Olivennes F, Feldberg D, Liu HC, Cohen J, Moy F, Rosenwaks Z. Endometriosis: a stage by stage analysis—the role of in vitro fertilization. Fertil Steril 1995; 64 (2) 392-398
- 7 Geber S, Paraschos T, Atkinson G, Margara R, Winston RM. Results of IVF in patients with endometriosis: the severity of the disease does not affect outcome, or the incidence of miscarriage. Hum Reprod 1995; 10 (6) 1507-1511
- 8 Hickman TN. Data from the Wilford Hall Medical Center IVF-ET Program. Impact of endometriosis on implantation. J Reprod Med 2002; 47 (10) 801-808
- 9 Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril 2002; 77 (6) 1148-1155
- 10 Omland AK, Abyholm T, Fedorcsák P , et al. Pregnancy outcome after IVF and ICSI in unexplained, endometriosis-associated and tubal factor infertility. Hum Reprod 2005; 20 (3) 722-727
- 11 Karita M, Yamashita Y, Hayashi A , et al. Does advanced-stage endometriosis affect the gene expression of estrogen and progesterone receptors in granulosa cells?. Fertil Steril 2011; 95 (3) 889-894
- 12 Matson PL, Yovich JL. The treatment of infertility associated with endometriosis by in vitro fertilization. Fertil Steril 1986; 46 (3) 432-434
- 13 Chillik CF, Acosta AA, Garcia JE , et al. The role of in vitro fertilization in infertile patients with endometriosis. Fertil Steril 1985; 44 (1) 56-61
- 14 Azem F, Lessing JB, Geva E , et al. Patients with stages III and IV endometriosis have a poorer outcome of in vitro fertilization-embryo transfer than patients with tubal infertility. Fertil Steril 1999; 72 (6) 1107-1109
- 15 Pal L, Shifren JL, Isaacson KB, Chang Y, Leykin L, Toth TL. Impact of varying stages of endometriosis on the outcome of in vitro fertilization-embryo transfer. J Assist Reprod Genet 1998; 15 (1) 27-31
- 16 Kuivasaari P, Hippeläinen M, Anttila M, Heinonen S. Effect of endometriosis on IVF/ICSI outcome: stage III/IV endometriosis worsens cumulative pregnancy and live-born rates. Hum Reprod 2005; 20 (11) 3130-3135
- 17 Ballester M, Oppenheimer A, d'Argent EM , et al. Nomogram to predict pregnancy rate after ICSI-IVF cycle in patients with endometriosis. Hum Reprod 2012; 27 (2) 451-456
- 18 Yanushpolsky EH, Best CL, Jackson KV, Clarke RN, Barbieri RL, Hornstein MD. Effects of endometriomas on oocyte quality, embryo quality, and pregnancy rates in in vitro fertilization cycles: a prospective, case-controlled study. J Assist Reprod Genet 1998; 15 (4) 193-197
- 19 Al-Azemi M, Bernal AL, Steele J, Gramsbergen I, Barlow D, Kennedy S. Ovarian response to repeated controlled stimulation in in-vitro fertilization cycles in patients with ovarian endometriosis. Hum Reprod 2000; 15 (1) 72-75
- 20 Somigliana E, Infantino M, Benedetti F, Arnoldi M, Calanna G, Ragni G. The presence of ovarian endometriomas is associated with a reduced responsiveness to gonadotropins. Fertil Steril 2006; 86 (1) 192-196
- 21 Benaglia L, Pasin R, Somigliana E, Vercellini P, Ragni G, Fedele L. Unoperated ovarian endometriomas and responsiveness to hyperstimulation. Hum Reprod 2011; 26 (6) 1356-1361
- 22 Almog B, Shehata F, Sheizaf B, Tan SL, Tulandi T. Effects of ovarian endometrioma on the number of oocytes retrieved for in vitro fertilization. Fertil Steril 2011; 95 (2) 525-527
- 23 Ballester M, Oppenheimer A, Mathieu d'Argent E , et al. Deep infiltrating endometriosis is a determinant factor of cumulative pregnancy rate after intracytoplasmic sperm injection/in vitro fertilization cycles in patients with endometriomas. Fertil Steril 2012; 97 (2) 367-372
- 24 Surrey MW, Hill DL. Treatment of endometriosis by carbon dioxide laser during gamete intrafallopian transfer. J Am Coll Surg 1994; 179 (4) 440-442
- 25 Surrey ES, Schoolcraft WB. Does surgical management of endometriosis within 6 months of an in vitro fertilization-embryo transfer cycle improve outcome?. J Assist Reprod Genet 2003; 20 (9) 365-370
- 26 Bedaiwy MA, Falcone T, Katz E, Goldberg JM, Assad R, Thornton J. Association between time from endometriosis surgery and outcome of in vitro fertilization cycles. J Reprod Med 2008; 53 (3) 161-165
- 27 Opøien HK, Fedorcsak P, Byholm T, Tanbo T. Complete surgical removal of minimal and mild endometriosis improves outcome of subsequent IVF/ICSI treatment. Reprod Biomed Online 2011; 23 (3) 389-395
- 28 Bianchi PH, Pereira RM, Zanatta A, Alegretti JR, Motta EL, Serafini PC. Extensive excision of deep infiltrative endometriosis before in vitro fertilization significantly improves pregnancy rates. J Minim Invasive Gynecol 2009; 16 (2) 174-180
- 29 Shahine LK, Burney RO, Behr B, Milki AA, Westphal LM, Lathi RB. Embryo quality before and after surgical treatment of endometriosis in infertile patients. J Assist Reprod Genet 2009; 26 (2–3) 69-73
- 30 Tsoumpou I, Kyrgiou M, Gelbaya TA, Nardo LG. The effect of surgical treatment for endometrioma on in vitro fertilization outcomes: a systematic review and meta-analysis. Fertil Steril 2009; 92 (1) 75-87
- 31 Benschop L, Farquhar C, van der Poel N, Heineman MJ. Interventions for women with endometrioma prior to assisted reproductive technology. Cochrane Database Syst Rev 2010; (11) CD008571
- 32 Khamsi F, Yavas Y, Lacanna IC, Roberge S, Endman M, Wong JC. Exposure of human oocytes to endometrioma fluid does not alter fertilization or early embryo development. J Assist Reprod Genet 2001; 18 (2) 106-109
- 33 Almog B, Sheizaf B, Shalom-Paz E, Shehata F, Al-Talib A, Tulandi T. Effects of excision of ovarian endometrioma on the antral follicle count and collected oocytes for in vitro fertilization. Fertil Steril 2010; 94 (6) 2340-2342
- 34 Somigliana E, Ragni G, Benedetti F, Borroni R, Vegetti W, Crosignani PG. Does laparoscopic excision of endometriotic ovarian cysts significantly affect ovarian reserve? Insights from IVF cycles. Hum Reprod 2003; 18 (11) 2450-2453
- 35 Esinler I, Bozdag G, Aybar F, Bayar U, Yarali H. Outcome of in vitro fertilization/intracytoplasmic sperm injection after laparoscopic cystectomy for endometriomas. Fertil Steril 2006; 85 (6) 1730-1735
- 36 Ho HY, Lee RK, Hwu YM, Lin MH, Su JT, Tsai YC. Poor response of ovaries with endometrioma previously treated with cystectomy to controlled ovarian hyperstimulation. J Assist Reprod Genet 2002; 19 (11) 507-511
- 37 Benaglia L, Somigliana E, Vighi V, Ragni G, Vercellini P, Fedele L. Rate of severe ovarian damage following surgery for endometriomas. Hum Reprod 2010; 25 (3) 678-682
- 38 Alborzi S, Ravanbakhsh R, Parsanezhad ME, Alborzi M, Alborzi S, Dehbashi S. A comparison of follicular response of ovaries to ovulation induction after laparoscopic ovarian cystectomy or fenestration and coagulation versus normal ovaries in patients with endometrioma. Fertil Steril 2007; 88 (2) 507-509
- 39 Marconi G, Vilela M, Quintana R, Sueldo C. Laparoscopic ovarian cystectomy of endometriomas does not affect the ovarian response to gonadotropin stimulation. Fertil Steril 2002; 78 (4) 876-878
- 40 Donnez J, Wyns C, Nisolle M. Does ovarian surgery for endometriomas impair the ovarian response to gonadotropin?. Fertil Steril 2001; 76 (4) 662-665
- 41 Garcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod 2009; 24 (3) 496-501
- 42 Hughes EG, Fedorkow DM, Collins JA. A quantitative overview of controlled trials in endometriosis-associated infertility. Fertil Steril 1993; 59 (5) 963-970
- 43 Surrey ES, Silverberg KM, Surrey MW , et al. The effect of prolonged GnRH agonist therapy on in vitro fertilization-embryo transfer cycle outcome in endometriosis patients: a multicenter randomized trial. Fertil Steril 2002; 78 (4) 699-704
- 44 Chedid S, Camus M, Smitz J, Van Steirteghem AC, Devroey P. Comparison among different ovarian stimulation regimens for assisted procreation procedures in patients with endometriosis. Hum Reprod 1995; 10 (9) 2406-2411
- 45 Wardle PG, Foster PA, Mitchell JD , et al. Endometriosis and IVF: effect of prior therapy. Lancet 1986; 1 (8475) 276-277
- 46 Remorgida V, Anserini P, Croce S, Costa M, Ferraiolo A, Capitanio GL. Comparison of different ovarian stimulation protocols for gamete intrafallopian transfer in patients with minimal and mild endometriosis. Fertil Steril 1990; 53 (6) 1060-1063
- 47 Curtis P, Jackson A, Bernard A, Shaw RW. Pretreatment with gonadotrophin releasing hormone (GnRH) analogue prior to in vitro fertilisation for patients with endometriosis. Eur J Obstet Gynecol Reprod Biol 1993; 52 (3) 211-216
- 48 Dicker D, Goldman GA, Ashkenazi J, Feldberg D, Voliovitz I, Goldman JA. The value of pre-treatment with gonadotrophin releasing hormone (GnRH) analogue in IVF-ET therapy of severe endometriosis. Hum Reprod 1990; 5 (4) 418-420
- 49 Marcus SF, Edwards RG. High rates of pregnancy after long-term down-regulation of women with severe endometriosis. Am J Obstet Gynecol 1994; 171 (3) 812-817
- 50 Nakamura K, Oosawa M, Kondou I , et al. Menotropin stimulation after prolonged gonadotropin releasing hormone agonist pretreatment for in vitro fertilization in patients with endometriosis. J Assist Reprod Genet 1992; 9 (2) 113-117
- 51 Rickes D, Nickel I, Kropf S, Kleinstein J. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis. Fertil Steril 2002; 78 (4) 757-762
- 52 Sallam HN, Garcia-Velasco JA, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev 2006; (1) CD004635
- 53 Sharpe-Timms KL, Keisler LW, McIntush EW, Keisler DH. Tissue inhibitor of metalloproteinase-1 concentrations are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotropin-releasing hormone agonist therapy. Fertil Steril 1998; 69 (6) 1128-1134
- 54 Ferrero S, Gillott DJ, Remorgida V, Anserini P, Ragni N, Grudzinskas JG. GnRH analogue remarkably down-regulates inflammatory proteins in peritoneal fluid proteome of women with endometriosis. J Reprod Med 2009; 54 (4) 223-231
- 55 Bilotas M, Barañao RI, Buquet R, Sueldo C, Tesone M, Meresman G. Effect of GnRH analogues on apoptosis and expression of Bcl-2, Bax, Fas and FasL proteins in endometrial epithelial cell cultures from patients with endometriosis and controls. Hum Reprod 2007; 22 (3) 644-653
- 56 Wang J, Zhou F, Dong M, Wu R, Qian Y. Prolonged gonadotropin-releasing hormone agonist therapy reduced expression of nitric oxide synthase in the endometrium of women with endometriosis and infertility. Fertil Steril 2006; 85 (4) 1037-1044
- 57 Lessey BA. Medical management of endometriosis and infertility. Fertil Steril 2000; 73 (6) 1089-1096
- 58 Ruan HC, Zhu XM, Luo Q , et al. Ovarian stimulation with GnRH agonist, but not GnRH antagonist, partially restores the expression of endometrial integrin beta3 and leukaemia-inhibitory factor and improves uterine receptivity in mice. Hum Reprod 2006; 21 (10) 2521-2529
- 59 Surrey ES, Minjarez DA, Schoolcraft WB. The incidence of aberrant endometrial alphavbeta(3) vitronectin expression in a high risk infertility population: could prolonged GnRH agonist therapy play a role?. J Assist Reprod Genet 2007; 24 (11) 553-556
- 60 Miller PB, Parnell BA, Bushnell G , et al. Endometrial receptivity defects during IVF cycles with and without letrozole. Hum Reprod 2012; 27 (3) 881-888
- 61 Farrell R, Gray D, Gindlesperger V , et al. Treatment of αvβ3 integrin abnormalities increases pregnancy success rates after failing IVF cycles. Fertil Steril 2003; 80 (Suppl. 03) S58
- 62 Surrey ES, Lietz AK, Gustofson RL, Minjarez DA, Schoolcraft WB. Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?. Fertil Steril 2010; 93 (2) 646-651
- 63 Barash A, Dekel N, Fieldust S, Segal I, Schechtman E, Granot I. Local injury to the endometrium doubles the incidence of successful pregnancies in patients undergoing in vitro fertilization. Fertil Steril 2003; 79 (6) 1317-1322
- 64 Raziel A, Schachter M, Strassburger D, Bern O, Ron-El R, Friedler S. Favorable influence of local injury to the endometrium in intracytoplasmic sperm injection patients with high-order implantation failure. Fertil Steril 2007; 87 (1) 198-201
- 65 Tei C, Maruyama T, Kuji N, Miyazaki T, Mikami M, Yoshimura Y. Reduced expression of alphavbeta3 integrin in the endometrium of unexplained infertility patients with recurrent IVF-ET failures: improvement by danazol treatment. J Assist Reprod Genet 2003; 20 (1) 13-20
- 66 de Ziegler D, Gayet V, Aubriot FX , et al. Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes. Fertil Steril 2010; 94 (7) 2796-2799
- 67 D'Hooghe TM, Denys B, Spiessens C, Meuleman C, Debrock S. Is the endometriosis recurrence rate increased after ovarian hyperstimulation?. Fertil Steril 2006; 86 (2) 283-290
- 68 Benaglia L, Somigliana E, Santi G, Scarduelli C, Ragni G, Fedele L. IVF and endometriosis-related symptom progression: insights from a prospective study. Hum Reprod 2011; 26 (9) 2368-2372